Literature DB >> 833870

Differences in breast cancer between Japan and the United States.

T Nemoto, T Tominaga, A Chamberlain, Z Iwasa, H Koyama, M Hama, I Bross, T Dao.   

Abstract

Two surgically treated series of 375 Japanese and 352 American women with breast cancer were compared with respect to overall survival and recurrence-free survival rates. Recurrence-free survival rates in Japanese women were superior to those in American women. Overall survival rates were also better in Japanese women, although the difference was not nearly as great as for recurrence-free survival. This seemed due to an improved survival after metastasis in the American women. In analyzing recurrence-free survival rates by age, we found that Japanese women 40 to 54 years old had better recurrence-free survival rates than other age subgroups. This age advantage was not observed in American women. For other age groups, there was relatively little advantage in survivorship in the Japanese series.

Entities:  

Mesh:

Year:  1977        PMID: 833870     DOI: 10.1093/jnci/58.2.193

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  10 in total

1.  Controversies in the Surgical Management of Operable Breast Cancer.

Authors: 
Journal:  Breast Cancer       Date:  1994-12-30       Impact factor: 4.239

Review 2.  Ethnic variation in breast cancer survival: a review.

Authors:  L Le Marchand
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

3.  Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast.

Authors:  M Noguchi; T Taniya; N Ohta; N Koyasaki; I Miyazaki; Y Mizukami
Journal:  Breast Cancer Res Treat       Date:  1991-09       Impact factor: 4.872

4.  Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer.

Authors:  M Noguchi
Journal:  Ann Surg       Date:  1995-04       Impact factor: 12.969

5.  A breast cancer Nutrition Adjuvant Study (NAS): protocol design and initial patient adherence.

Authors:  R T Chlebowski; D W Nixon; G L Blackburn; P Jochimsen; E F Scanlon; W Insull; I M Buzzard; R Elashoff; R Butrum; E L Wynder
Journal:  Breast Cancer Res Treat       Date:  1987-10       Impact factor: 4.872

Review 6.  Response to treatment of breast cancer.

Authors:  J L Berenberg
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

7.  Hepatic metastases in Hong Kong Chinese: evidence for an East-West difference in gastric cancer.

Authors:  R J Steele; S C Chung; A K Li; T J Crofts
Journal:  Ann R Coll Surg Engl       Date:  1987-03       Impact factor: 1.891

8.  A comparison of breast cancers detected by mass screening and those found in out-patient clinics.

Authors:  M Noguchi; M Earashi; N Ohta; H Kitagawa; M Thomas; I Miyazaki
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

9.  The relationship between lymph node metastases and DNA-ploidy status as prognostic factors in invasive breast cancer.

Authors:  M Noguchi; N Ohta; N Koyasaki; T Taniya; I Miyazaki; Y Mizukami
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

10.  Stage-specific breast-cancer incidence rates by age among Japanese and Caucasian women in Hawaii, 1960-1979.

Authors:  M Ward-Hinds; L N Kolonel; A M Nomura; J Lee
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.